Clinical Trial Update: Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need Ventilators [Phase 1, Phase 2]

View source ↗

Summary

Astellas Gene Therapies reports that ASP2957 is being studied in male participants with X-linked myotubular myopathy who need ventilators, in Phase 1/Phase 2, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• X-linked Myotubular Myopathy

Drugs mentioned

• ASP2957

Snippet

Sponsor: Astellas Gene Therapies | Conditions: X-Linked Myotubular Myopathy | Phase 1, Phase 2 | Status: RECRUITING